TABLE 1.
Fibroblasts (name or donor) | Origin | % Positive cellsb
|
||||
---|---|---|---|---|---|---|
CD14 (Leu-M3) | CD14 (MEM-18) | CD18 | CD54 | HLA-DR | ||
IMR-90 | Lung | 0.4 | 1.1 | 0.2 | 91.4 | 0.5 |
WI-38 | Lung | 0.4 | 3.9 | 1.1 | 76.9 | 0.9 |
MRC-5 | Lung | 1.1 | 0.5 | 1.3 | 80.9 | 1.2 |
FS-4 | Skin | 0.5 | 0.7 | 0.4 | 70.1 | 0.2 |
SF-MA | Skin | 1.4 | 1.9 | 1.2 | 41.5 | 1.6 |
HN | Gingiva | 1.4 | 17.2 | 0.7 | 50.2 | 0.7 |
KT | Gingiva | 1.5 | 19.1 | 0.9 | 46.4 | 1.2 |
MH | Gingiva | 6.3 | 56.1 | 0.8 | 51.2 | 0.6 |
MM | Gingiva | 15.5 | 52.9 | 0.5 | 55.1 | 0.7 |
MY | Gingiva | 14.7 | 51.9 | 0.9 | 50.6 | 1.5 |
NK | Gingiva | 1.9 | 10.6 | 0.7 | 40.4 | 0.7 |
SM | Gingiva | 15.6 | 66.3 | 1.1 | 19.5 | 1.2 |
TT | Gingiva | 15.1 | 53.2 | 0.6 | 78.1 | 0.8 |
YN | Gingiva | 1.5 | 9.6 | 0.8 | 87.8 | 0.6 |
Fibroblasts from confluent cultures were collected and stained with the MAbs indicated.
The percentage of positive cells was analyzed by flow cytometry.